IKK:Biophysical basis of dynamic regulation
IKK:动态调节的生物物理基础
基本信息
- 批准号:8463406
- 负责人:
- 金额:$ 50.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2015-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdverse effectsAffectAnalytical CentrifugationArchitectureArthritisAtherosclerosisBindingBinding SitesBiochemicalBiochemical ReactionBiochemistryBiological AssayBiophysicsCatalytic DomainCell LineCell Surface ReceptorsCellsCharacteristicsChronicChronic DiseaseComplexComputer SimulationCoupledCrystallographyDevelopmentDiseaseDissociationDoseDrug TargetingEffectivenessEnzymesEquationEstimation TechniquesFamilyFeedbackGenesGeneticGoalsHalf-LifeHeat-Shock Proteins 90Human PathologyIkappaB kinaseImmuneImmune responseIn VitroInflammatoryInflammatory ResponseInterleukin-1InterventionKineticsLesionLibrariesMalignant Epithelial CellMalignant NeoplasmsMapsMass Spectrum AnalysisMeasuresMediatingMethodologyModelingMolecularMolecular ChaperonesMonitorMultienzyme ComplexesNF-kappa BNatural regenerationNeoplasm MetastasisNucleotidesOutcomePathogenesisPathologyPathway interactionsPeptide HydrolasesPharmaceutical PreparationsPharmacological TreatmentPhosphoric Monoester HydrolasesPhosphorylationPhosphorylation SitePhosphotransferasesPhysiologicalPhysiologyPlayProtein DephosphorylationProtein KinaseProtein Phosphatase 2A Regulatory Subunit PR53ProteinsReactionReceptor CellReceptor Down-RegulationRecyclingRegulationReportingRestRoleScaffolding ProteinSignal TransductionSignaling ProteinSpecificitySquamous cell carcinomaStimulusStreamStructureStructure-Activity RelationshipStudy modelsTNF geneTestingTherapeuticTherapeutic InterventionTumor Necrosis Factor ReceptorWorkautocrinebasecancer cellcancer typecell typecrosslinkcytokinedesignhigh throughput screeningimmune activationin vivoinhibitor/antagonistmathematical modelmutantnovelparacrinereaction ratereceptorreconstitutionresearch studyresponseself assemblysimulationsmall moleculesrc-Family Kinasestext searchingtranscription factorubiquitin ligaseupstream kinase
项目摘要
IKK is the major signaling hub for inflammatory and innate immune responses. It is an enzyme complex that
receives signals from a large number of cellular receptors regulates that activity of the NF-kB family of transcription
factors. Misregulation of IKK is associated with many chronic diseases, such as chronic inflammatory pathologies
(arthritis, atherosclerosis, etc) and many different types of cancer. Genetic evidence strongly supports IKK's critical
and central role in many functions in physiology and pathology, but its potential as a drug target has not been
realized. Mechanistic and biophysical studies have been lacking, and we have neither a kinetic understanding of
IKK regulation nor structural information. However, what is clear is that IKK mediates signaling specificity by tight
dynamic control that is stimulus-specific and induces the expression of specific sets of genes. Recent studies have
reported on a tightly coupled activation and inactivation mechanism that can only be described by a multi-state
activation-inactivation cycle that involves the function of several enzymes with different functions, such as ubiquitin
ligases, kinases, phosphatases, and foldases. Through regulation of these activities, we hypothesize that the IKK
cycle is driven in a stimulus- and cell type-specific manner, and that understanding the kinetic relationships will
reveal opportunities for rationally targeted pharmacological intervention that discriminate between disease
associated misregulation and stimulus-responsive regulation in healthy cells.
In this proposal, we will construct a mathematical model of the IKK cycle to explore the dynamic regulation of IKK
activity. We will then focus biochemical and biophysical studies on specific control mechanisms. In particular, we
test the roles of IKK oligomerization, conformational changes, and upstream kinases in IKK activation and inhibition
of IKK. Computational simulations will guide genetic and pharmacological manipulation of IKK dynamics. Finally, we
will focus our study on how TNF and IL-1 produce differential dynamic control of IKK; how differential dose response
and temporal control determine the efficacy of cytokine traps.
IKK是炎症和先天免疫反应的主要信号中枢。这是一种酶复合物
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Probing kinase activation and substrate specificity with an engineered monomeric IKK2.
- DOI:10.1021/bi401551r
- 发表时间:2014-04-01
- 期刊:
- 影响因子:2.9
- 作者:Hauenstein AV;Rogers WE;Shaul JD;Huang DB;Ghosh G;Huxford T
- 通讯作者:Huxford T
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GOURISANKAR GHOSH其他文献
GOURISANKAR GHOSH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GOURISANKAR GHOSH', 18)}}的其他基金
Suppressing Inflammation by Blocking IKK Oligomer
通过阻断 IKK 寡聚物抑制炎症
- 批准号:
10446098 - 财政年份:2022
- 资助金额:
$ 50.65万 - 项目类别:
Suppressing Inflammation by Blocking IKK Oligomer
通过阻断 IKK 寡聚物抑制炎症
- 批准号:
10573218 - 财政年份:2022
- 资助金额:
$ 50.65万 - 项目类别:
Investigation of Gene Regulation by NF-kappaB Transcription factors
NF-kappaB 转录因子基因调控的研究
- 批准号:
8260199 - 财政年份:2009
- 资助金额:
$ 50.65万 - 项目类别:
Investigation of gene regulation by NF-kappaB transcription factors
NF-κB转录因子基因调控的研究
- 批准号:
9021868 - 财政年份:2009
- 资助金额:
$ 50.65万 - 项目类别:
Cofactor-Mediated DNA Binding by the NF-kappaB Dimers
NF-kappaB 二聚体辅助因子介导的 DNA 结合
- 批准号:
9887959 - 财政年份:2009
- 资助金额:
$ 50.65万 - 项目类别:
Investigation of gene regulation by NF-kappaB transcription factors
NF-κB转录因子基因调控的研究
- 批准号:
8904029 - 财政年份:2009
- 资助金额:
$ 50.65万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 50.65万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 50.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 50.65万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 50.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 50.65万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 50.65万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 50.65万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 50.65万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 50.65万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 50.65万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




